We are live on
!
Find out more
Acadia Pharmaceuticals
ACAD
ACAD
319 hedge funds and large institutions have $2.87B invested in Acadia Pharmaceuticals in 2025 Q1 according to their latest regulatory filings, with 63 funds opening new positions, 102 increasing their positions, 102 reducing their positions, and 37 closing their positions.
New
Increased
Maintained
Reduced
Closed
426% more call options, than puts
Call options by funds: $30.3M | Put options by funds: $5.77M
70% more first-time investments, than exits
New positions opened: 63 | Existing positions closed: 37
8% more funds holding
Funds holding: 295 → 319 (+24)
5.79% more ownership
Funds ownership: 97.91% → 103.71% (+5.8%)
0% more repeat investments, than reductions
Existing positions increased: 102 | Existing positions reduced: 102
4% less capital invested
Capital invested by funds: $2.99B → $2.87B (-$116M)
40% less funds holding in top 10
Funds holding in top 10: 5 → 3 (-2)
Holders
319
Holders Change
+24
Holders Change %
+8.14%
% of All Funds
4.28%
Holding in Top 10
3
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-40%
% of All Funds
0.04%
New
63
Increased
102
Reduced
102
Closed
37
Calls
$30.3M
Puts
$5.77M
Net Calls
+$24.6M
Net Calls Change
+$13.9M
Top Buyers
| 1 |
BlackRock
New York
|
+$157M |
| 2 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
+$66.5M |
| 3 |
State Street
Boston,
Massachusetts
|
+$44.9M |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$43.9M |
| 5 |
American Century Companies
Kansas City,
Missouri
|
+$27.1M |
Top Sellers
| 1 |
Morgan Stanley
New York
|
-$47.5M |
| 2 |
SG Americas Securities
New York
|
-$44.8M |
| 3 |
Man Group
London,
United Kingdom
|
-$18.6M |
| 4 |
Millennium Management
New York
|
-$18.5M |
| 5 |
D.E. Shaw & Co
New York
|
-$16.2M |
